Sestak, I
72  results:
Search for persons X
?
2

Comparison of StemPrintER with Oncotype DX Recurrence Score..:

Pece S ; Sestak I ; Montani F...
info:eu-repo/semantics/altIdentifier/pmid/35172273.  , 2022
 
?
7

Off-treatment bone mineral density changes in postmenopausa..:

Sestak, I ; Blake, G ; Patel, R...
https://eprints.whiterose.ac.uk/170712/1/s41416-020-01228-2.pdf.  , 2021
 
?
9

The impact of body mass index on breast cancer incidence am..:

Smith, SG ; Sestak, I ; Morris, MA...
https://eprints.whiterose.ac.uk/171822/8/s10549-021-06141-7.pdf.  , 2021
 
?
13

Use of anastrozole for breast cancer prevention (IBIS-II): ..:

Cuzick, J ; Sestak, I ; Forbes, JF...
Lancet (London, England), 2020, 395 (10218), pp. 117 - 122.  , 2020
 
?
15

Molecular Drivers of Onco type DX, Prosigna, EndoPredict, a..:

Buus, R ; Sestak, I ; Kronenwett, R...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 39 (2), pp. 126 - 135.  , 2020
 
1-15